Literature DB >> 22385119

Homeobox C5 expression is associated with the progression of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.

Sung-Min Moon1, Mee-Young Ahn, Seong-Min Kwon, Soo-A Kim, Sang-Gun Ahn, Jung-Hoon Yoon.   

Abstract

BACKGROUND: Aberrant expression of homeobox genes (HOX), normally required for the differentiation of a particular tissue, has been reported in several types of cancer, but poorly addressed in oral squamous cell carcinoma (OSCC). The present study investigated the expression of HOXC5 in OSCC and identified molecular biomarker whose expression is associated with the multistep oral carcinogenesis.
METHODS: The expression of HOXC5, proliferation cell nuclear antigen (PCNA), and Bcl-2 was examined by RT-PCR and Western blot analysis and confirmed by immunohistochemistry and transferase-mediated dUTP nick end-labeling (TUNEL) assay in a 4-nitroquinoline 1-oxide (4NQO)-induced rat tongue carcinogenesis model.
RESULTS: Homeobox genes C5 was overexpressed in SCC tissues, but not in normal tissues by RT-PCR and Western blot analysis. Along with the progress of multistep carcinogenesis, the levels of HOXC5 expression of mRNA and protein significantly increased during the dysplasia (moderate to severe dysplasia) when compared with normal and hyperplasia. The levels of PCNA and Bcl-2 were sequentially increased from hyperplasia to dysplasia and SCC. By immunohistochemistry, HOXC5 expression was significantly increased in dysplasia, whereas PCNA expression was gradually increased during tongue carcinogenesis. TUNEL-positive cells were increased until dysplasia, but reduced in SCC.
CONCLUSIONS: These results indicate that overexpression of HOXC5 is correlated with oral carcinogenesis and strongly contributed to the development of OSCC. HOXC5 may be a useful biomarker and has an emerging therapeutic target of OSCC.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22385119     DOI: 10.1111/j.1600-0714.2012.01133.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  HOXA10 controls proliferation, migration and invasion in oral squamous cell carcinoma.

Authors:  Manoela Carrera; Carolina C Bitu; Carine Ervolino de Oliveira; Nilva K Cervigne; Edgard Graner; Aki Manninen; Tuula Salo; Ricardo D Coletta
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

2.  Designing a Mucoadhesive ChemoPatch to Ablate Oral Dysplasia for Cancer Prevention.

Authors:  Xiaoqin Liu; Qian Li; Yang Wang; Madeleine Crawford; Parnit K Bhupal; Xiuqing Gao; Huan Xie; Dong Liang; Yi-Shing L Cheng; Xiaohua Liu; Robert Y L Tsai
Journal:  Small       Date:  2022-05-19       Impact factor: 15.153

3.  Integrated computational analysis reveals HOX genes cluster as oncogenic drivers in head and neck squamous cell carcinoma.

Authors:  U Sangeetha Shenoy; Richard Morgan; Keith Hunter; Shama Prasada Kabekkodu; Raghu Radhakrishnan
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.996

4.  MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.

Authors:  Xiaolong You; Zhengyu Zhou; Wen Chen; Xiaoyong Wei; Heqiang Zhou; Wenzheng Luo
Journal:  Stem Cell Res Ther       Date:  2020-03-14       Impact factor: 6.832

5.  Novel cytological model for the identification of early oral cancer diagnostic markers: The carcinoma sequence model.

Authors:  Masami Kawaharada; Manabu Yamazaki; Satoshi Maruyama; Tatsuya AbÉ; Nyein Nyein Chan; Taiichi Kitano; Tadaharu Kobayashi; Takeyasu Maeda; Jun-Ichi Tanuma
Journal:  Oncol Lett       Date:  2022-01-11       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.